THE STRUCTURAL REALITY & PRIVATE SENIOR LIVING · US
Your residents' families chose you because they expect more than management.
The data says they're watching closely.
Healos™ cellular nutrition program for private Assisted Living & Memory Care · Florida & New York
91
Day Program ·
20
High-risk residents
20
Measurable Outcomes
| ~68% of cardiac residents | On statins — CoQ10 depleted 40–50%. Fatigue prevents rehab completion. |
| ~52% on loop diuretics | K · Mg · Thiamine depleted. Electrolyte-driven arrhythmia and weakness. |
| 40–50% of cardiac patients | Clinical fear of recurrence. Untracked. Multiplies all other risk (×0.4). |
| Complex polypharmacy | 3–6 concurrent medications typical. Drug-nutrient conflicts compound. |
| No GP access (6.5M Canadians) | Residents waiting for LTC often have no regular physician to intercept decline. |
| Healos™ Trial: 20 patients | Targets all five mechanisms simultaneously. 3-month measurable outcome. |
🛡 All protocols pharmacist-reviewed against complex polypharmacy regimens 📋 Monthly H-Index report for every enrolled resident — shareable with clinical team
🔒 HIPAA & PIPEDA · Private Firestore Vault per resident 📊 Contractual inflammation targets — measurable, verifiable outcomes
THE STRUCTURAL CRISIS - THE NUMBERS
The Waiting List Won't Shorten
Until Your Current Residents Get Better.
These are the structural conditions driving the LTC capacity crisis. Healos™ is designed specifically for this gap
— not as wellness, but as a measurable cellular health intervention for your highest-risk residents.
87.9%
· US assisted living occupancy 2026 — revenue lost in the empty 12.1%
22 months
Average resident length of stay — shortened by unmanaged decline
41%
Annual staff turnover rate — driven by reactive, high-intensity care burden
$5,419/mo
Median private-pay monthly fee — at risk when families move loved ones out
The mechanism: When AL and memory care residents have unaddressed drug-nutrient depletions, subclinical inflammation, and mitochondrial energy deficits — they decline faster, generate more acute care transfers, require more intensive staff intervention per shift, and leave sooner. Each of these outcomes directly reduces your revenue, increases your operational cost, and shortens the tenure of the residents your team worked hard to admit.
Healos™ addresses all four mechanisms simultaneously — in a structured, pharmacist-reviewed, monthly-tracked program.
THE HEALOS™ LTC TRIAL PROPOSAL
20 high-risk residents. 3 months.
Measurable outcomes before you commit to anything larger.
The Trial is structured to protect your institution. You select the patients. You set the
outcome expectations. We deliver the data. The long-term contract is conditional on
hitting the agreed targets.
The 20-Patient · 3-Month · LTC Trial
Structured to demonstrate measurable outcome before full institutional commitment
WHAT THE TRIAL MEANS FOR EACH DECISION-MAKER
CEO / EXECUTIVE DIRECTOR
Occupancy, Length of stay & competitive positioning
Every 1-point improvement in resident quality of life adds an average 85 days to length of stay — at $5,419/month, that is $15,000+ in additional revenue per resident
Measurable reduction in per-resident acute care transfer events — the highest single-incident cost in private AL operations
First community in your market offering structured cellular health tracking — a documented differentiator for family decision-makers comparing facilities
91-day outcome data package suitable for family communication, board reporting, and marketing collateral
DIRECTOR OF CARE (DOC)
Resident stability & care team burden
Monthly H-Index™ report per resident — a clinical picture between physician visits, shareable with attending MD
hs-CRP and CoQ10 blood panel before/after comparison at Day 91 — objective inflammation data in the resident record
Drug-nutrient interaction review for residents on 5+ concurrent medications — flags unaddressed polypharmacy gaps before they become acute events
AI-automated daily tracking — near-zero additional nursing workload; no protocol changes required for your floor team
Marketing DIRECTOR (DOM)
Family satisfaction, referral reputation & move-in conversion
J.D. Power 2025 data shows family satisfaction with AL/memory care is driven by dining, resident activities, and visible wellbeing — precisely what cellular health improvement delivers
Documented resident health improvement creates the referral story families actually tell: “She’s stronger than when she moved in”
91-day outcome report gives your sales team a concrete, data-backed answer to the #1 family objection: “Will my parent actually improve here?”
As acuity levels continue to rise in AL and memory care, a proactive outcome-driven model is the competitive separator operators are looking for — Healos™ gives your community that narrative with verifiable data seniorhousingnews
Healos™ nutritional formulations are dietary supplements compliant with FDA DSHEA framework · No prescription required ·
Pharmacist-reviewed against resident medication profiles
TRIAL SEQUENCE
Step 1
Patient Selection
DOC identifies 20 high-risk residents: elevated hs-CRP · multiple cardiac medications · transfer-risk flags · functional plateau
Step 2
H-Index baseline + pharmacist review
32-dimension baseline audit for each resident. Full drug-nutrient interaction screen before any supplement is introduced. Warfarin/anticoagulant patients screened first.
Step 3
3-month protocol + monthly reporting
3-stage cellular protocol delivered. Monthly H-Index PDF per resident for your clinical team. 24/7 AI monitoring. Day-45 mid-point data review.
Step 4
Day-91 outcome report & contract decision
Full before/after blood panel comparison. H-Index 91-day arc. Clinical outcome summary. If targets met — long-term contract for 100+ patients offered.
We will respond personally within 48 hours · Proposal includes full pricing, target metrics, and contract terms
INSTITUTIONAL ECONOMICS
The economics of the Healos™ institutional model
How the Healos™ Sovereign Node partnership changes the economics of long-term care delivery
— for institutions that integrate it as a structured resident health programme.
Institutional partnership enquiries: Healos™ is building a network of private senior living partners across Florida and New York. The 20-resident Trial is the entry point — the long-term programme (full community, 80–150+ residents) is what the partnership becomes. Nutritional formulations are dietary supplements compliant with the FDA DSHEA framework · Pharmacist-reviewed against resident medication profiles · No prescription required · NPN application in progress with Health Canada for Canadian institutional partners.
Contact us directly for a proposal specific to your community's size, resident population, and current care metrics.
Healos™ Patient Programmes
Appointment Anxiety With Congenital Heart Disease | Healos™
Lifelong check-ups can bring dread before every scan and result. Why appointment anxiety is common with congenital heart disease, and how to cope. ...more
Core Health Pillars ,The Healos™ Way Wellness & Lifestyle Clinical Frontiers &ACHD
November 03, 2026•14 min read
The 91-Day Protocol, Week by Week | Healos™
From checkout to day 90: the pharmacist review, the Detox, Replenish and Repair stages, follow-ups at days 30 and 60, and the day-90 review. ...more
Core Health Pillars ,The Healos™ Way Leadership & Assetization Clinical Frontiers CAD STK ACHD &PRV
October 30, 2026•10 min read
After Cardiac Rehab Ends: What to Do Next | Healos™
Cardiac rehab is over and nobody is watching your heart rate anymore. How to exercise safely on your own, what to track, and how to avoid the rehab cliff. ...more
Core Health Pillars ,The Healos™ Way Clinical Frontiers &CAD
October 29, 2026•22 min read
Healos™ Canada — Integrative cellular recovery for post-cardiac, post-stroke, and ACHD patients.
Canada.USA.Mexico.Japan.China.Singapore.Australia...
SMS & voicemail: 365.909.2567
Ottawa, Ontario, Canada
PATIENT SERVICES
© 2026 Healos™ Canada · NoHeartAttack.com · Ottawa, Ontario Privacy - Terms - Refunds
Healos™ programmes are dietary supplements and integrative wellness services. They are not medical advice, not medical treatment, and not a substitute for professional medical care.
Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme. In case of cardiac emergency, call 911 immediately. Healos™ Canada